T. Rowe Price Associates’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $55.7M | Buy |
1,547,544
+1,157,016
| +296% | +$41.6M | 0.01% | 701 |
|
2025
Q1 | $15.4M | Buy |
390,528
+93,427
| +31% | +$3.68M | ﹤0.01% | 1013 |
|
2024
Q4 | $8.94M | Buy |
297,101
+215,601
| +265% | +$6.49M | ﹤0.01% | 1167 |
|
2024
Q3 | $1.91M | Sell |
81,500
-6,421
| -7% | -$150K | ﹤0.01% | 1663 |
|
2024
Q2 | $1.57M | Buy |
87,921
+2,318
| +3% | +$41.3K | ﹤0.01% | 1686 |
|
2024
Q1 | $1.3M | Buy |
85,603
+5,015
| +6% | +$76.3K | ﹤0.01% | 1779 |
|
2023
Q4 | $1.38M | Buy |
80,588
+27,249
| +51% | +$466K | ﹤0.01% | 1714 |
|
2023
Q3 | $446K | Sell |
53,339
-244,700
| -82% | -$2.05M | ﹤0.01% | 2158 |
|
2023
Q2 | $7.4M | Buy |
298,039
+223,545
| +300% | +$5.55M | ﹤0.01% | 1120 |
|
2023
Q1 | $1.12M | Sell |
74,494
-18,172
| -20% | -$273K | ﹤0.01% | 1730 |
|
2022
Q4 | $1.1M | Sell |
92,666
-11,917
| -11% | -$141K | ﹤0.01% | 1728 |
|
2022
Q3 | $620K | Buy |
104,583
+4,326
| +4% | +$25.6K | ﹤0.01% | 2012 |
|
2022
Q2 | $426K | Sell |
100,257
-480,718
| -83% | -$2.04M | ﹤0.01% | 2278 |
|
2022
Q1 | $5.53M | Sell |
580,975
-17
| -0% | -$162 | ﹤0.01% | 1449 |
|
2021
Q4 | $11M | Sell |
580,992
-844,156
| -59% | -$16M | ﹤0.01% | 1395 |
|
2021
Q3 | $47.4M | Sell |
1,425,148
-458,503
| -24% | -$15.3M | ﹤0.01% | 1031 |
|
2021
Q2 | $73.1M | Buy |
1,883,651
+266,310
| +16% | +$10.3M | 0.01% | 896 |
|
2021
Q1 | $78M | Buy |
1,617,341
+216,496
| +15% | +$10.4M | 0.01% | 848 |
|
2020
Q4 | $72.9M | Buy |
1,400,845
+1,349,836
| +2,646% | +$70.2M | 0.01% | 830 |
|
2020
Q3 | $1.37M | Buy |
+51,009
| New | +$1.37M | ﹤0.01% | 1673 |
|
2018
Q4 | – | Sell |
-39,297
| Closed | -$220K | – | 2581 |
|
2018
Q3 | $220K | Buy |
39,297
+349
| +0.9% | +$1.95K | ﹤0.01% | 2429 |
|
2018
Q2 | $512K | Sell |
38,948
-788
| -2% | -$10.4K | ﹤0.01% | 2126 |
|
2018
Q1 | $564K | Sell |
39,736
-13,000
| -25% | -$185K | ﹤0.01% | 2036 |
|
2017
Q4 | $432K | Buy |
52,736
+38,000
| +258% | +$311K | ﹤0.01% | 2128 |
|
2017
Q3 | $175K | Hold |
14,736
| – | – | ﹤0.01% | 2422 |
|
2017
Q2 | $148K | Buy |
14,736
+36
| +0.2% | +$362 | ﹤0.01% | 2433 |
|
2017
Q1 | $171K | Hold |
14,700
| – | – | ﹤0.01% | 2425 |
|
2016
Q4 | $68K | Hold |
14,700
| – | – | ﹤0.01% | 2499 |
|
2016
Q3 | $114K | Buy |
+14,700
| New | +$114K | ﹤0.01% | 2429 |
|